Research programme: ion channel modulators - Knopp Biosciences

Drug Profile

Research programme: ion channel modulators - Knopp Biosciences

Alternative Names: Kv7 channel activators

Latest Information Update: 22 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Knopp Biosciences
  • Class Small molecules
  • Mechanism of Action Potassium channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Epilepsy; Neuropathic pain; Tinnitus

Most Recent Events

  • 16 Feb 2017 Knopp receives SBIR grant from the National Institutes of Health Blueprint Neurotherapeutics Network for development in Epilepsy
  • 26 Jan 2017 Knopp Biosciences has patent protection for Ion channel activators in USA
  • 26 Jan 2017 Knopp Biosciences has patents pending for compositions of activating ion channels
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top